A Cochrane database review explored the effects of supervised dosing in opioid substitution therapy.

Children of women who are prescribed opioids are at significant risk for opioid overdose.

From being critiqued by Bernie Sanders to the controversial Duchenne drug approval decision, Dr Califf recounts his experiences as FDA commissioner.

Dr Cyrus Desouza reviews GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors, offering advice on which patients may benefit from each class.

Frustrated by the slow development of new antibiotics? Paul Auwaerter, MD, offers a quick review of some of the latest approaches to this problem.

Drs Shubrook and Pfotenhauer review the details of prescribing insulin and the importance of ordering all supplies needed for your patients.

Dr Ranit Mishori discusses best practices for guiding patients away from inappropriate medications.

What comes after basal insulin? Join us for a discussion of basal-plus therapy and tips for adding rapid insulin and GLP-1 receptor agonists.

With this review of the new literature, Dr David Johnson wants to put the risks associated with proton pump inhibitors into perspective and quiet the noise.

Cardiology and hematology experts from Mayo Clinic review how and when DOACs should be deployed in patients with nonvalvular atrial fibrillation or at risk for VTE. They also address approved and pipeline reversal agents.